These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 34743199)
21. Naquotinib exerts antitumor activity in activated B-cell-like diffuse large B-cell lymphoma. Tanaka H; Kaneko N; Sakagami H; Matsuya T; Hiramoto M; Yamanaka Y; Mori M; Koshio H; Hirano M; Takeuchi M Leuk Res; 2020 Jan; 88():106286. PubMed ID: 31865062 [TBL] [Abstract][Full Text] [Related]
22. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo. Chen Z; You L; Wang L; Huang X; Liu H; Wei JY; Zhu L; Qian W J Exp Clin Cancer Res; 2018 Aug; 37(1):190. PubMed ID: 30103789 [TBL] [Abstract][Full Text] [Related]
23. BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab. Iqbal J; Meyer PN; Smith LM; Johnson NA; Vose JM; Greiner TC; Connors JM; Staudt LM; Rimsza L; Jaffe E; Rosenwald A; Ott G; Delabie J; Campo E; Braziel RM; Cook JR; Tubbs RR; Gascoyne RD; Armitage JO; Weisenburger DD; Chan WC Clin Cancer Res; 2011 Dec; 17(24):7785-95. PubMed ID: 21933893 [TBL] [Abstract][Full Text] [Related]
24. Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach. de Jong MRW; Visser L; Huls G; Diepstra A; van Vugt M; Ammatuna E; van Rijn RS; Vellenga E; van den Berg A; Fehrmann RSN; van Meerten T PLoS One; 2018; 13(2):e0193098. PubMed ID: 29489886 [TBL] [Abstract][Full Text] [Related]
25. Expression of the αVβ3 integrin affects prostate cancer sEV cargo and density and promotes sEV pro-tumorigenic activity in vivo through a GPI-anchored receptor, NgR2. Verrillo CE; Quaglia F; Shields CD; Lin S; Kossenkov AV; Tang HY; Speicher D; Naranjo NM; Testa A; Kelly WK; Liu Q; Leiby B; Musante L; Sossey-Alaoui K; Dogra N; Chen TY; Altieri DC; Languino LR J Extracell Vesicles; 2024 Aug; 13(8):e12482. PubMed ID: 39105261 [TBL] [Abstract][Full Text] [Related]
26. Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. Qing K; Jin Z; Xu Z; Wang W; Li X; Zhang Y; Wang L; Zhu H; Xiang R; Wu S; Li R; Jiang G; Xue K; Li J Chemotherapy; 2022; 67(1):12-23. PubMed ID: 34844236 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma. Huang J; Guo P; Ma D; Lin X; Fang Q; Wang J Int J Oncol; 2016 Jul; 49(1):253-64. PubMed ID: 27211510 [TBL] [Abstract][Full Text] [Related]
28. Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression. Zhang LH; Kosek J; Wang M; Heise C; Schafer PH; Chopra R Br J Haematol; 2013 Feb; 160(4):487-502. PubMed ID: 23252516 [TBL] [Abstract][Full Text] [Related]
29. Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapy. Li Q; Huang J; Ou Y; Li Y; Wu Y Immunotherapy; 2019 Mar; 11(4):265-272. PubMed ID: 30606076 [TBL] [Abstract][Full Text] [Related]
30. Tropomyosin Receptor Kinase B Agonist, 7,8-Dihydroxyflavone, Improves Mitochondrial Respiration in Placentas From Obese Women. Prince CS; Maloyan A; Myatt L Reprod Sci; 2018 Mar; 25(3):452-462. PubMed ID: 28677406 [TBL] [Abstract][Full Text] [Related]
31. Protein Kinase D1, Reduced in Human Pancreatic Tumors, Increases Secretion of Small Extracellular Vesicles From Cancer Cells That Promote Metastasis to Lung in Mice. Armacki M; Polaschek S; Waldenmaier M; Morawe M; Ruhland C; Schmid R; Lechel A; Tharehalli U; Steup C; Bektas Y; Li H; Kraus JM; Kestler HA; Kruger S; Ormanns S; Walther P; Eiseler T; Seufferlein T Gastroenterology; 2020 Sep; 159(3):1019-1035.e22. PubMed ID: 32446697 [TBL] [Abstract][Full Text] [Related]
32. L-Type Cav 1.2 Calcium Channel-α-1C Regulates Response to Rituximab in Diffuse Large B-Cell Lymphoma. Zhang JY; Zhang PP; Zhou WP; Yu JY; Yao ZH; Chu JF; Yao SN; Wang C; Lone W; Xia QX; Ma J; Yang SJ; Liu KD; Dong ZG; Guo YJ; Smith LM; McKeithan TW; Chan WC; Iqbal J; Liu YY Clin Cancer Res; 2019 Jul; 25(13):4168-4178. PubMed ID: 30824586 [TBL] [Abstract][Full Text] [Related]
33. Down-regulation of cylindromatosis protein phosphorylation by BTK inhibitor promotes apoptosis of non-GCB-diffuse large B-cell lymphoma. Xu X; Wei T; Zhong W; Ang R; Lei Y; Zhang H; Li Q Cancer Cell Int; 2021 Apr; 21(1):195. PubMed ID: 33827598 [TBL] [Abstract][Full Text] [Related]
35. PI3K/AKT inhibition reverses R-CHOP resistance by destabilizing SOX2 in diffuse large B cell lymphoma. Chen J; Ge X; Zhang W; Ding P; Du Y; Wang Q; Li L; Fang L; Sun Y; Zhang P; Zhou Y; Zhang L; Lv X; Li L; Zhang X; Zhang Q; Xue K; Gu H; Lei Q; Wong J; Hu W Theranostics; 2020; 10(7):3151-3163. PubMed ID: 32194860 [TBL] [Abstract][Full Text] [Related]
36. MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program. Hu S; Xu-Monette ZY; Tzankov A; Green T; Wu L; Balasubramanyam A; Liu WM; Visco C; Li Y; Miranda RN; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Zhao X; van Krieken JH; Huang Q; Huh J; Ai W; Ponzoni M; Ferreri AJ; Zhou F; Slack GW; Gascoyne RD; Tu M; Variakojis D; Chen W; Go RS; Piris MA; Møller MB; Medeiros LJ; Young KH Blood; 2013 May; 121(20):4021-31; quiz 4250. PubMed ID: 23449635 [TBL] [Abstract][Full Text] [Related]
37. High TSPAN8 expression in epithelial cancer cell-derived small extracellular vesicles promote confined diffusion and pronounced uptake. Wang T; Wang X; Wang H; Li L; Zhang C; Xiang R; Tan X; Li Z; Jiang C; Zheng L; Xiao L; Yue S J Extracell Vesicles; 2021 Nov; 10(13):e12167. PubMed ID: 34796683 [TBL] [Abstract][Full Text] [Related]
39. [Establishment and characterization of a nude mice model of human diffuse large B-cell lymphoma]. Yu BH; Zhou XY; Zhang TC; Zhang TM; Shi DR Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):246-50. PubMed ID: 21615998 [TBL] [Abstract][Full Text] [Related]
40. Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease. Chapuy B; Cheng H; Watahiki A; Ducar MD; Tan Y; Chen L; Roemer MG; Ouyang J; Christie AL; Zhang L; Gusenleitner D; Abo RP; Farinha P; von Bonin F; Thorner AR; Sun HH; Gascoyne RD; Pinkus GS; van Hummelen P; Wulf GG; Aster JC; Weinstock DM; Monti S; Rodig SJ; Wang Y; Shipp MA Blood; 2016 May; 127(18):2203-13. PubMed ID: 26773040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]